{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:13:05Z","timestamp":1793459585258,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes, Taiwan","doi-asserted-by":"crossref","award":["NHRI-EX95, 96, 97, 98, 99-9511PP; NHRI-EX100-10048PI"],"award-info":[{"award-number":["NHRI-EX95, 96, 97, 98, 99-9511PP; NHRI-EX100-10048PI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"crossref","award":["97HP0023"],"award-info":[{"award-number":["97HP0023"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bali Psychiatric Center","award":["99R001"],"award-info":[{"award-number":["99R001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12888-019-2204-6","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T13:02:37Z","timestamp":1562936557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"An-Sheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chieh","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-5870","authenticated-orcid":false,"given":"Wei J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2204_CR1","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J, American Psychiatric Association Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161:1\u201356."},{"key":"2204_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.psc.2007.04.001","volume":"30","author":"H Elkis","year":"2007","unstructured":"Elkis H. Treatment-resistant schizophrenia. Psychiatr Clin North Am. 2007;30:511\u201333.","journal-title":"Psychiatr Clin North Am"},{"key":"2204_CR3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0010-440X(66)80028-7","volume":"7","author":"TM Itil","year":"1966","unstructured":"Itil TM, Keskiner A, Fink M. Therapeutic studies in \"therapy resistant\" schizophrenic patients. Compr Psychiatry. 1966;7:488\u201393.","journal-title":"Compr Psychiatry"},{"key":"2204_CR4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0006-3223(01)01271-9","volume":"50","author":"RR Conley","year":"2001","unstructured":"Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry. 2001;50:898\u2013911.","journal-title":"Biol Psychiatry"},{"key":"2204_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, et al. Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174:216\u201329.","journal-title":"Am J Psychiatry"},{"key":"2204_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789\u201396.","journal-title":"Arch Gen Psychiatry"},{"key":"2204_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.psychres.2015.10.036","volume":"230","author":"VM Anderson","year":"2015","unstructured":"Anderson VM, McIlwain ME, Kydd RR, Russell BR. Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders? Psychiatry Res. 2015;230:811\u20138.","journal-title":"Psychiatry Res"},{"key":"2204_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.psc.2016.01.006","volume":"39","author":"H Elkis","year":"2016","unstructured":"Elkis H, Buckley PF. Treatment-resistant schizophrenia. Psychiatr Clin North Am. 2016;39:239\u201365.","journal-title":"Psychiatr Clin North Am."},{"key":"2204_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","volume":"44","author":"DR Weinberger","year":"1987","unstructured":"Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"2204_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/schbul\/18.2.319","volume":"18","author":"RM Murray","year":"1992","unstructured":"Murray RM, O'Callaghan E, Castle DJ, Lewis SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull. 1992;18:319\u201332.","journal-title":"Schizophr Bull"},{"key":"2204_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/schbul\/sbn187","volume":"35","author":"SH Fatemi","year":"2009","unstructured":"Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 2009;35:528\u201348.","journal-title":"Schizophr Bull"},{"key":"2204_CR12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/mp.2012.23","volume":"17","author":"JL Rapoport","year":"2012","unstructured":"Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry. 2012;17:1228\u201338.","journal-title":"Mol Psychiatry"},{"key":"2204_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0022-3956(97)00052-6","volume":"32","author":"BB Sheitman","year":"1998","unstructured":"Sheitman BB, Lieberman JA. The natural history and pathophysiology of treatment resistant schizophrenia. J Psychiatr Res. 1998;32:143\u201350.","journal-title":"J Psychiatr Res"},{"key":"2204_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry. 2012;169:1203\u201310.","journal-title":"Am J Psychiatry"},{"key":"2204_CR15","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","volume":"75","author":"A Demjaha","year":"2014","unstructured":"Demjaha A, Egerton A, Murray RM, Kapur S, Howes OD, Stone JM, McGuire PK. Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function. Biol Psychiatry. 2014;75:e11\u20133.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"2204_CR16","doi-asserted-by":"publisher","first-page":"pyu117","DOI":"10.1093\/ijnp\/pyu117","volume":"18","author":"M. E. Goldstein","year":"2015","unstructured":"Goldstein ME, Anderson VM, Pillai A, Kydd RR, Russell BR. Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia. Int J Neuropsychopharmacol. 2015;18.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"2204_CR17","doi-asserted-by":"publisher","first-page":"pyv016","DOI":"10.1093\/ijnp\/pyv016","volume":"18","author":"VM Anderson","year":"2015","unstructured":"Anderson VM, Goldstein ME, Kydd RR, Russell BR. Extensive gray matter volume reduction in treatment-resistant schizophrenia. Int J Neuropsychopharmacol. 2015;18:pyv016.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2204_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","volume":"17","author":"AL Gillespie","year":"2017","unstructured":"Gillespie AL, Samanaite R, Mill J, Egerton A, MacCabe JH. Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review. BMC Psychiatry. 2017;17:12.","journal-title":"BMC Psychiatry"},{"key":"2204_CR19","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1017\/S0033291714002931","volume":"45","author":"AS Lin","year":"2015","unstructured":"Lin AS, Chang SS, Lin SH, Peng YC, Hwu HG, Chen WJ. Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia. Psychol Med. 2015;45:1839\u201350.","journal-title":"Psychol Med"},{"key":"2204_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.pnpbp.2017.09.002","volume":"81","author":"A de Bartolomeis","year":"2018","unstructured":"de Bartolomeis A, Prinzivalli E, Callovini G, D'Ambrosio L, Altavilla B, Avagliano C, Iasevoli F. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: evidence from explanatory analysis on clinical, psychopathological, and cognitive variables. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;81:356\u201366.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2204_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1017\/S1355617717001114","volume":"23","author":"LJ Seidman","year":"2017","unstructured":"Seidman LJ, Mirsky AF. Evolving notions of schizophrenia as a developmental neurocognitive disorder. J Int Neuropsychol Soc. 2017;23:881\u201392.","journal-title":"J Int Neuropsychol Soc"},{"issue":"Suppl 2","key":"2204_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4088\/JCP.14074su1c.02","volume":"77","author":"MF Green","year":"2016","unstructured":"Green MF. Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia. J Clin Psychiatry. 2016;77(Suppl 2):8\u201311.","journal-title":"J Clin Psychiatry."},{"key":"2204_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","volume":"160","author":"II Gottesman","year":"2003","unstructured":"Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636\u201345.","journal-title":"Am J Psychiatry"},{"key":"2204_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/h0039381","volume":"20","author":"LH Beck","year":"1956","unstructured":"Beck LH, Bransome ED Jr, Mirsky AF, Rosvold HE, Sarason I. A continuous performance test of brain damage. J Consult Psychol. 1956;20:343\u201350.","journal-title":"J Consult Psychol"},{"key":"2204_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","volume":"165","author":"KH Nuechterlein","year":"2008","unstructured":"Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203\u201313.","journal-title":"Am J Psychiatry"},{"key":"2204_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ajmg.b.32166","volume":"162B","author":"WJ Chen","year":"2013","unstructured":"Chen WJ. Taiwan schizophrenia linkage study: lessons learned from endophenotype-based genome-wide linkage scans and perspective. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:636\u201347.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2204_CR27","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1981.01780340058007","volume":"38","author":"RF Asarnow","year":"1981","unstructured":"Asarnow RF, MacCrimmon DJ. Span of apprehension deficits during the postpsychotic stages of schizophrenia. A replication and extension. Arch Gen Psychiatry. 1981;38:1006\u201311.","journal-title":"Arch Gen Psychiatry"},{"key":"2204_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/schbul\/10.2.160","volume":"10","author":"KH Nuechterlein","year":"1984","unstructured":"Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull. 1984;10:160\u2013203.","journal-title":"Schizophr Bull"},{"key":"2204_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/schbul\/sbl055","volume":"33","author":"RE Gur","year":"2007","unstructured":"Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS. The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophr Bull. 2007;33:49\u201368.","journal-title":"Schizophr Bull"},{"key":"2204_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0893-133X(99)00137-2","volume":"22","author":"SK Liu","year":"2000","unstructured":"Liu SK, Chen WJ, Chang CJ, Lin HN. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol. Neuropsychopharmacology. 2000;22:311\u20139.","journal-title":"Neuropsychopharmacology."},{"key":"2204_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.schres.2006.03.045","volume":"87","author":"HC Tsuang","year":"2006","unstructured":"Tsuang HC, Lin SH, Liu SK, Hsieh MH, Hwang TJ, Liu CM, Hwu HG, Chen WJ. More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophr Res. 2006;87:172\u201380.","journal-title":"Schizophr Res"},{"key":"2204_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/schbul\/sbs141","volume":"39","author":"SH Lin","year":"2013","unstructured":"Lin SH, Liu CM, Hwang TJ, Hsieh MH, Hsiao PC, Faraone SV, Tsuang MT, Hwu HG, Chen WJ. Performance on the Wisconsin card sorting test in families of schizophrenia patients with different familial loadings. Schizophr Bull. 2013;39:537\u201346.","journal-title":"Schizophr Bull"},{"key":"2204_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000319807","volume-title":"Therapy-resistant schizophrenia","author":"N Woodward","year":"2010","unstructured":"Woodward N, Meltzer H. Neuropsychology of treatment-resistant schizophrenia. In: Elkis H, Meltzer H, editors. Therapy-resistant schizophrenia, vol. 26. Basel (Switzerland): Karger; 2010. p. 33\u201351."},{"key":"2204_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.psychres.2013.06.042","volume":"210","author":"A de Bartolomeis","year":"2013","unstructured":"de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses. Psychiatry Res. 2013;210:387\u201395.","journal-title":"Psychiatry Res"},{"key":"2204_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.psychres.2015.11.028","volume":"235","author":"D Frydecka","year":"2016","unstructured":"Frydecka D, Beszlej JA, Goscimski P, Kiejna A, Misiak B. Profiling cognitive impairment in treatment-resistant schizophrenia patients. Psychiatry Res. 2016;235:133\u20138.","journal-title":"Psychiatry Res"},{"key":"2204_CR36","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, Md.: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976."},{"key":"2204_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.v64n0301","volume":"64","author":"JM Kane","year":"2003","unstructured":"Kane JM, Leucht S, Carpenter D, Docherty JP. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry. 2003;64:5\u201319.","journal-title":"J Clin Psychiatry"},{"key":"2204_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/oxfordjournals.schbul.a033308","volume":"24","author":"WJ Chen","year":"1998","unstructured":"Chen WJ, Hsiao CK, Hsiao LL, Hwu HG. Performance of the continuous performance test among community samples. Schizophr Bull. 1998;24:163\u201374.","journal-title":"Schizophr Bull"},{"key":"2204_CR39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.182.4116.990","volume":"182","author":"JA Swets","year":"1973","unstructured":"Swets JA. The relative operating characteristic in psychology: a technique for isolating effects of response bias finds wide use in the study of perception and cognition. Science. 1973;182:990\u20131000.","journal-title":"Science."},{"key":"2204_CR40","first-page":"397","volume-title":"Handbook of schizophrenia: neuropsychology, psychophysiology, and information processing","author":"KH Nuechterlein","year":"1991","unstructured":"Nuechterlein KH. Vigilance in schizophrenia and related disorders. In: Steinhauer SR, Gruzelier JH, Zubin J, editors. Handbook of schizophrenia: neuropsychology, psychophysiology, and information processing, vol. 5. Amsterdam: Elsevier Science; 1991. p. 397\u2013433."},{"key":"2204_CR41","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1176\/ajp.155.9.1214","volume":"155","author":"WJ Chen","year":"1998","unstructured":"Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry. 1998;155:1214\u201320.","journal-title":"Am J Psychiatry"},{"key":"2204_CR42","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.biopsych.2004.01.010","volume":"55","author":"WJ Chen","year":"2004","unstructured":"Chen WJ, Chang CH, Liu SK, Hwang TJ, Hwu HG. Sustained attention deficits in nonpsychotic relatives of schizophrenic patients: a recurrence risk ratio analysis. Biol Psychiatry. 2004;55:995\u20131000.","journal-title":"Biol Psychiatry"},{"key":"2204_CR43","first-page":"204","volume":"31","author":"AC Elliott","year":"2006","unstructured":"Elliott AC, Reisch JS. Implementing a multiple comparison test for proportions in a 2xc crosstabulation in SAS\u00ae. Proceedings of the SAS User's Group International. 2006;31:204\u201331.","journal-title":"Proceedings of the SAS User's Group International"},{"key":"2204_CR44","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2147\/NDT.S47571","volume":"9","author":"F Iasevoli","year":"2013","unstructured":"Iasevoli F, Balletta R, Gilardi V, Giordano S, de Bartolomeis A. Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment. Neuropsychiatr Dis Treat. 2013;9:1113\u201320.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2204_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pnpbp.2013.07.010","volume":"52","author":"KM Mackowick","year":"2014","unstructured":"Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet-Plamondon C, George TP. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;52:79\u201385.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2204_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1126\/science.6836276","volume":"220","author":"KH Nuechterlein","year":"1983","unstructured":"Nuechterlein KH, Parasuraman R, Jiang Q. Visual sustained attention: image degradation produces rapid sensitivity decrement over time. Science. 1983;220:327\u20139.","journal-title":"Science."},{"key":"2204_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0165-1781(89)90188-1","volume":"29","author":"BA Cornblatt","year":"1989","unstructured":"Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res. 1989;29:65\u201385.","journal-title":"Psychiatry Res"},{"key":"2204_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.schres.2015.01.017","volume":"163","author":"KH Nuechterlein","year":"2015","unstructured":"Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, et al. Attention\/vigilance in schizophrenia: performance results from a large multi-site study of the consortium on the genetics of schizophrenia (COGS). Schizophr Res. 2015;163:38\u201346.","journal-title":"Schizophr Res"},{"key":"2204_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-1781(88)90076-5","volume":"26","author":"BA Cornblatt","year":"1988","unstructured":"Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families. Psychiatry Res. 1988;26:223\u201338.","journal-title":"Psychiatry Res"},{"key":"2204_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2012.09.009","volume":"142","author":"PV Kahn","year":"2012","unstructured":"Kahn PV, Walker TM, Williams TS, Cornblatt BA, Mohs RC, Keefe RS. Standardizing the use of the continuous performance test in schizophrenia research: a validation study. Schizophr Res. 2012;142:153\u20138.","journal-title":"Schizophr Res"},{"key":"2204_CR51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jpsychires.2006.06.010","volume":"40","author":"SK Liu","year":"2006","unstructured":"Liu SK, Hsieh MH, Hwang TJ, Hwu HG, Liao SC, Lin SH, Chen WJ. Re-examining sustained attention deficits as vulnerability indicators for schizophrenia: stability in the long term course. J Psychiatr Res. 2006;40:613\u201321.","journal-title":"J Psychiatr Res"},{"key":"2204_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","volume":"72","author":"KH Nuechterlein","year":"2004","unstructured":"Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72:29\u201339.","journal-title":"Schizophr Res"},{"key":"2204_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.schres.2015.01.027","volume":"163","author":"LJ Seidman","year":"2015","unstructured":"Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the consortium on the genetics of schizophrenia (COGS-1). Schizophr Res. 2015;163:73\u20139.","journal-title":"Schizophr Res"},{"key":"2204_CR54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/mp.2014.56","volume":"20","author":"J Frank","year":"2015","unstructured":"Frank J, Lang M, Witt SH, Strohmaier J, Rujescu D, Cichon S, Degenhardt F, Nothen MM, Collier DA, Ripke S, et al. Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients. Mol Psychiatry. 2015;20:150\u20131.","journal-title":"Mol Psychiatry"},{"key":"2204_CR55","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0006-3223(95)00588-9","volume":"39","author":"JI Epstein","year":"1996","unstructured":"Epstein JI, Keefe RSE, Roitman SL, Harvey PD, Mohs RC. Impact of neuroleptic medications on continuous performance test measures in schizophrenia. Biol Psychiatry. 1996;39:902\u20135.","journal-title":"Biol Psychiatry"},{"key":"2204_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376.","journal-title":"Schizophr Bull"},{"key":"2204_CR57","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating-scale. Psychol Rep. 1962;10:799\u2013812.","journal-title":"Psychol Rep"},{"key":"2204_CR58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1017\/S0033291703008900","volume":"34","author":"G Brebion","year":"2004","unstructured":"Brebion G, Bressan RA, Amador X, Malaspina D, Gorman JM. Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs. Psychol Med. 2004;34:369\u201374.","journal-title":"Psychol Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2204-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:07:57Z","timestamp":1594422477000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2204-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2204"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2204-6","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board of the Bali Psychiatric Center approved the study (IRB990309\u201301). We obtained written informed consent from all the participants after providing a complete description of the study. Each subject\u2019s identifier was removed and replaced by a code.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}